Drug Trial Radar · NCT07206758
Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia
Last checked: Nov 19, 2026Latest source record: May 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
10
Planned (sponsor's estimate)
Start
Nov 12, 2025
Primary completion
Jun 2026
Study completion Nov 2026
Sponsor
- Lead sponsor
- Guangdong Hengrui Pharmaceutical Co., LtdIndustry
- Sponsor type
- Industry
- First posted
- Oct 3, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Evaluate the safety and tolerance of multiple subcutaneous injections of SHR-2173 in ITP patients
Conditions
- Immune Thrombocytopenia
Interventions
SHR-2173 InjectionDrug
SHR-2173 injection treatment
Primary outcomes
What the sponsor says the trial is designed to measure.
- The incidence of adverse events (AE) and serious adverse events (SAE) and adverse events of special concern (AESI)Time frame: About in the ninth month
- The severity of adverse events (AE) and serious adverse events (SAE) and adverse events of special concern (AESI)Time frame: About in the ninth month
- Changes in abnormal indicators in laboratory inspectionTime frame: About in the ninth month
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.